All lobbying filings

Bluebird Strategies

Bluebird Strategies filed a Q4 report for Thermo Fisher Scientific Inc. on January 21, 2026, reporting $12,000 in lobbying income.

Lobbying for Thermo Fisher Scientific Inc. · Scientific product and technology company.

As filed: BLUEBIRD STRATEGIES for THERMO FISHER SCIENTIFIC INC.

All filings by Bluebird Strategies · Everything Thermo Fisher Scientific Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 21, 2026

Income

$12,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Engage Senate and House on proposed legislation to promote the appropriate use of FDA cleared preeclampsia biomarker testing as part of the Medicaid program

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.